rtki cpd has been researched along with Cancer of the Thyroid in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Higashiyama, S; Hosoi, H; Masui, T; Matsuura, N; Ota, I; Yane, K | 1 |
| Allolio, B; Buck, AK; Germer, CT; Lorenz, U; Ritter, CO; Wiegering, A | 1 |
| Clark, OH; Duh, QY; Park, JW; Rougier, JP; Werb, Z; Wong, M; Yeh, MW | 1 |
| Bergström, JD; Heldin, NE; Westermark, B | 1 |
4 other study(ies) available for rtki cpd and Cancer of the Thyroid
| Article | Year |
|---|---|
Heparin-binding EGF-like growth factor enhances the activity of invasion and metastasis in thyroid cancer cells.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Neutralizing; Cell Line, Tumor; Cell Proliferation; Chemotaxis; Diphtheria Toxin; ErbB Receptors; Heparin-binding EGF-like Growth Factor; Humans; Intercellular Signaling Peptides and Proteins; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Quinazolines; Receptor, ErbB-4; RNA, Messenger; Thyroid Neoplasms; Tyrphostins | 2013 |
Early development of a celiac trunk aneurysm during anti-vascular endothelial growth factor receptor therapy.
Topics: Aged; Aneurysm; Celiac Artery; Enzyme Inhibitors; Female; Humans; Quinazolines; Receptors, Vascular Endothelial Growth Factor; Thyroid Neoplasms; Tomography, X-Ray Computed; Treatment Outcome; Tyrphostins; Withholding Treatment | 2014 |
Differentiated thyroid cancer cell invasion is regulated through epidermal growth factor receptor-dependent activation of matrix metalloproteinase (MMP)-2/gelatinase A.
Topics: Adenocarcinoma, Follicular; Aprotinin; Blotting, Western; Carcinoma, Papillary; Cell Differentiation; Dipeptides; Enzyme Activation; Enzyme Inhibitors; Epidermal Growth Factor; ErbB Receptors; Flow Cytometry; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase Inhibitors; Neoplasm Invasiveness; Protease Inhibitors; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Protein Tyrosine Phosphatases; Quinazolines; Reverse Transcriptase Polymerase Chain Reaction; Serine Proteinase Inhibitors; Tetracyclines; Thyroid Neoplasms; Tumor Cells, Cultured; Tyrphostins | 2006 |
Epidermal growth factor receptor signaling activates met in human anaplastic thyroid carcinoma cells.
Topics: Antineoplastic Agents; Butadienes; Carcinoma; Enzyme Inhibitors; ErbB Receptors; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; MAP Kinase Kinase Kinase 1; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Nitriles; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-met; Quinazolines; RNA, Messenger; Suramin; Thyroid Neoplasms; Transforming Growth Factor alpha; Tumor Cells, Cultured; Tyrphostins | 2000 |